亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北威德利化學科技有限公司  

醫藥原料與醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:魏琦
  • 電話:027-83778875
  • 郵件:15807197853@163.com
  • 傳真:027-83778875
  • QQ:3167471756
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家熱銷1-芐基哌嗪****
廠家熱銷1-芐基哌嗪****
單價 380.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 1000KG起訂25KG
品牌 湖北威德利-13971053654
型號 5321-63-1
規格 白色結晶性粉末
過期 長期有效
更新 2016-01-08 10:11
 
詳細信息

1-芐基哌嗪****

生產1-芐基哌嗪****廠家,湖北威德利化學熱銷1-芐基哌嗪****價格 魏琦 l3971O53654

中文名 1-芐基哌嗪****,N-芐基哌嗪****

英文名 1-Benzylpiperazine dihydrochloride

CAS RN 5321-63-1

分子式 C11H16N2·2(HCl) 分子量 249.18

外觀 1-芐基哌嗪****為白色結晶性粉末

熔點>251℃ 熾灼殘渣≤0.5%

水分≤0.5% 哌嗪≤0.5%

含量 1-芐基哌嗪****≥98.5%

作用 1-芐基哌嗪****用作頭孢類醫藥中間體

1-芐基哌嗪****包裝 25KG/紙板桶
生產1-芐基哌嗪****廠家,湖北威德利化學熱銷1-芐基哌嗪****價格 魏琦 l3971O53654

©2025 湖北威德利化學科技有限公司 版權所有   技術支持:化工網   訪問量:11424  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |